Soft Tissue Repair Market Size, Share & Trends Analysis | Global | 2026-2032 | MedSuite | Includes: Achilles Tendon Repair, Rotator Cuff Repair, and 5 more

Product Description

Overall, the global orthopedic soft tissue repair market was valued at over $5 billion in 2025. This is expected to increase over the forecast period at a CAGR of 5.3% to reach $7.3 billion.

The full report suite on the global market for orthopedic soft tissue repair includes Achilles tendon repair and reconstruction devices, rotator cuff repair and reconstruction devices, shoulder labrum repair devices, biceps tenodesis repair devices, anterior and posterior cruciate ligament (ACL/PCL) reconstruction products, meniscal repair devices and hip arthroscopy devices.

Data Types Included

• Unit Sales, Average Selling Prices, Market Size & Growth Trends
• Procedure Numbers
• Market Drivers & Limiters
• Market Forecasts Until 2032, and Historical Data to 2022
• Recent Mergers & Acquisitions
• Company Profiles and Product Portfolios
• Leading Competitors

Global Orthopedic Soft Tissue Repair Market Trends

The total market for orthopedic soft tissue repair products has been expanding, largely due to a notable increase in injury rates among an aging but active demographic. While professional sports players still represent the highest individual incidence rates, the sheer volume of procedures is now driven by broader public participation in high-impact fitness. Advances in minimally invasive techniques have also reduced the number of cases treated non-surgically, as patients in 2025 increasingly prioritize rapid surgical recovery over traditional conservative management.

Global Orthopedic Soft Tissue Repair Market Share Insights

• Arthrex‘s dominance in the sports medicine market is built on the breadth and depth of its implant portfolio across virtually every key surgical segment. In the rotator cuff space, the company’s SpeedBridge construct, anchored by its FiberTak RC soft anchors and SwiveLock knotless fixation system, has become one of the most widely adopted double-row repair techniques in the field. The FiberTak SpeedBridge technique uses 2.6 mm FiberTak RC soft anchors on the medial row and FiberTape sutures fixated laterally with SwiveLock anchors, enabling three points of medial-row fixation where previously only two could be achieved. For augmented repairs, the CuffMend system pairs a decellularized dermal allograft with FiberStitch RC implants and PushLock anchors to address challenging partial- and full-thickness repairs, particularly revisions or cases where retear risk is elevated due to poor tendon quality. On the knee side, Arthrex’s TightRope button fixation system remains a cornerstone of its ACL reconstruction portfolio, with the next-generation TightRope SB all-suture button technology eliminating metal hardware from the construct entirely. For meniscal repair, Arthrex’s ZoneNavigator system advances the inside-out technique with single-handed control of needle placement, delivering 2-0 SutureTape in precise 1 cm increments. The company’s shoulder instability offering is anchored by the FiberTak all-suture anchor, which has found widespread adoption in labral repair procedures owing to its low-profile knotless design and strong pullout characteristics.
• Smith & Nephew‘s sports medicine portfolio is differentiated by its strong emphasis on biological healing, and the REGENETEN Bioinductive Implant sits at the center of that strategy. The REGENETEN implant is a collagen scaffold that has been used in over 150,000 patients, with clinical data showing its fixation and delivery system enables a procedure lasting under 15 minutes. Following fixation, the implant is resorbed and replaced by a new layer of tendon-like tissue within six months, and has demonstrated a reduction in postoperative re-tear rates in full-thickness tears when used as an augment to standard repair. Smith+Nephew has actively expanded REGENETEN’s addressable market beyond the rotator cuff into the gluteus medius, Achilles tendon and other tendinopathies — a move that broadens the product’s relevance across the hip, knee and foot and ankle segments. In the meniscal repair segment, the NOVOSTITCH PRO enables surgeons to place stitches arthroscopically in tight joint compartments using a meniscus-to-meniscus circumferential compression stitch, allowing repair of previously unrepairable tear types, including horizontal cleavage tears. For rotator cuff fixation, the HEALICOIL REGENESORB suture anchor platform rounds out the shoulder portfolio with an open-architecture design that promotes bone ingrowth and is fully resorbed and replaced by bone within 24 months. In ACL reconstruction, the company launched the UltraTrac Quad system, which integrates the QuadTrac quadriceps tendon harvest guide, X-Wing graft preparation and UltraButton adjustable fixation into the first comprehensive guide system for minimally invasive quad tendon harvesting.
• DePuy Synthes competes in the global orthopedic soft tissue repair market primarily through its Mitek Sports Medicine franchise. In the ACL segment, the Milagro Advance biocomposite interference screw has been a long-standing product in the portfolio, constructed from Biocryl Rapide , a proprietary biocomposite material that resorbs over time and permits ossification of the implant site, reducing the long-term foreign-body burden associated with traditional metal or PEEK screws. For rotator cuff repair, the FASTIN RC threaded titanium anchor is specifically designed for soft tissue reattachment, while the Cuff Link device addresses the mechanical challenge of aggressive rehabilitation after rotator cuff surgery. In the meniscal segment, the CLEARFIX meniscal screw and the TRUESPAN all-inside meniscal repair system offer surgeons options across the spectrum of tear complexity, with TRUESPAN’s one-handed operation and curved needle design intended to improve access in challenging compartments. For hip arthroscopy, the Endurance hip solutions line addresses the growing labral repair and femoroacetabular impingement (FAI) market. Strategically, the most significant development for DePuy Synthes is the announced spin-off from Johnson & Johnson, with J&J announcing the planned divestiture of DePuy Synthes over an 18-to-24-month period beginning in October 2025. While the separation introduces near-term uncertainty, it also creates the opportunity for a more focused sports medicine strategy under dedicated leadership with Namal Nawana, former CEO of Smith+Nephew, appointed to lead the newly independent company.ccess tools. DePuy Synthes continues to focus on procedural efficiency and material versatility to stay competitive amid rising use of all-suture and knotless technologies.

Global Orthopedic Soft Tissue Repair Market Segmentation Summary

• Achilles Tendon Repair & Reconstruction Market – Further Segmented Into:
  • Graft Type: Allograft, Xenograft, and Synthetic.
  • Suture Anchor Type: Biocomposite, PEEK, and Metal.
• Rotator Cuff Repair & Reconstruction Market – Further Segmented Into:
  • Graft Type: Allograft, Xenograft, and Synthetic.
  • Suture Anchor Type: Biocomposite, PEEK, Metal, All-Suture, PEEK CF, and PLA.
• Shoulder Labrum Repair Market – Further Segmented Into:
  • Suture Anchor Type: Biocomposite, PEEK, Metal, All-Suture, PEEK CF, and PLA.
  • Device Type*: Knotless, and Knotted.
• Biceps Tenodesis Market – Further Segmented Into:
  • Device Type: Suture Anchor, and Screw.
• ACL/PCL Reconstruction Market – Further Segmented Into:
  • Allograft Type: Bone-Patella Tendon-Bone, Non-Sutured Soft Tissue, and Pre-Sutured Soft Tissue.
  • Fixation Device Type: Interference Screw, Cortical Fixation, Intratunnel Fixation, Washer and Post, and Cross-Pin.
• Meniscal Repair Market – Further Segmented Into:
  • Device Type: Implant, Suture, and Hybrid.
• Hip Arthroscopy Market – Further Segmented Into:
  • Device Type: Radiofrequency Probe, Banana Blade, Hip Access Kit, Suture Anchor, and Disposable Kit.

Research Scope Summary